ATE283368T1 - Für die glutamatabhängigen chloridkanäle kodierende dna - Google Patents

Für die glutamatabhängigen chloridkanäle kodierende dna

Info

Publication number
ATE283368T1
ATE283368T1 AT95920633T AT95920633T ATE283368T1 AT E283368 T1 ATE283368 T1 AT E283368T1 AT 95920633 T AT95920633 T AT 95920633T AT 95920633 T AT95920633 T AT 95920633T AT E283368 T1 ATE283368 T1 AT E283368T1
Authority
AT
Austria
Prior art keywords
host cells
glutamatate
chloride channels
recombinant host
dna coding
Prior art date
Application number
AT95920633T
Other languages
English (en)
Inventor
Doris F Cully
Joseph P Arena
Ken K Liu
Demetrios Vassilatis
Original Assignee
Merck & Co Inc
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Univ Columbia filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE283368T1 publication Critical patent/ATE283368T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95920633T 1994-05-25 1995-05-19 Für die glutamatabhängigen chloridkanäle kodierende dna ATE283368T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/249,112 US5527703A (en) 1994-05-25 1994-05-25 DNA encoding glutamate gated chloride channels
PCT/US1995/006556 WO1995032302A1 (en) 1994-05-25 1995-05-19 Dna encoding glutamate gated chloride channels

Publications (1)

Publication Number Publication Date
ATE283368T1 true ATE283368T1 (de) 2004-12-15

Family

ID=22942110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95920633T ATE283368T1 (de) 1994-05-25 1995-05-19 Für die glutamatabhängigen chloridkanäle kodierende dna

Country Status (8)

Country Link
US (1) US5527703A (de)
EP (1) EP0760864B1 (de)
JP (1) JP3623798B2 (de)
AT (1) ATE283368T1 (de)
CA (1) CA2191063C (de)
DE (1) DE69533796T2 (de)
ES (1) ES2232822T3 (de)
WO (1) WO1995032302A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276662B1 (it) * 1995-04-04 1997-11-03 Uni Degli Studi Camerino Vaccini polinucleotidici
US5693492A (en) * 1995-05-05 1997-12-02 Merck & Co., Inc. DNA encoding glutamate gated chloride channels
US5854411A (en) * 1997-01-09 1998-12-29 Incyte Pharmaceuticals, Inc. Human chloride channel
US6358701B1 (en) * 1997-08-11 2002-03-19 Merck & Co., Inc. DNA molecules encoding Ctenocephalides felis glutamate gated chloride channels
US6048692A (en) * 1997-10-07 2000-04-11 Motorola, Inc. Sensors for electrically sensing binding events for supported molecular receptors
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
US7033789B1 (en) 1999-10-22 2006-04-25 Merck & Co., Inc. DNA molecules encoding L-glutamate-gated chloride channels from Schistocerca americana
WO2001064705A1 (en) * 2000-03-02 2001-09-07 Merck & Co., Inc. Dna molecules encoding a glutamate-gated chloride channel in drosophila melanogaster
US7267964B2 (en) * 2000-03-31 2007-09-11 Merial Limited DNA molecules encoding ligand gated ion channels from Dermacentor variabilis
EP1294751B1 (de) * 2000-03-31 2014-03-05 Merial Limited Gaba-abhängige chloridkanäle aus dermacentor variabilis
US6329174B1 (en) * 2000-06-13 2001-12-11 Aventis Cropscience Sa Nucleic acid encoding lepidoteran glutamate-gated chloride channel
EP1581791A4 (de) * 2002-05-01 2007-08-01 Fmc Corp Verfahren zur messung von ionenkanalaktivität
AU2016332847B2 (en) * 2015-10-01 2023-08-10 Goleini Inc. Targeted expression of chloride channels and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ240921A (en) * 1990-12-12 1994-06-27 Zymogenetics Inc G protein coupled glutamate receptor (neurotransmitters), recombinant production
US5385831A (en) * 1990-12-12 1995-01-31 Zymogenetics, Inc. Method for producing a mammalian G protein coupled glutamate receptor
AU2343092A (en) * 1991-04-02 1992-12-21 Baylor College Of Medicine A high-affinity human glutamate/aspartate uptake system
GB9112504D0 (en) * 1991-06-11 1991-07-31 Merck Sharp & Dohme Cell line
WO1993007161A1 (en) * 1991-10-04 1993-04-15 Cornell Research Foundation, Inc. Molecular cloning and transformation of cyclodiene resistance
US5693492A (en) * 1995-05-05 1997-12-02 Merck & Co., Inc. DNA encoding glutamate gated chloride channels

Also Published As

Publication number Publication date
EP0760864A4 (de) 2000-02-02
CA2191063A1 (en) 1995-11-30
EP0760864A1 (de) 1997-03-12
US5527703A (en) 1996-06-18
CA2191063C (en) 2010-07-20
DE69533796D1 (de) 2004-12-30
DE69533796T2 (de) 2005-11-10
ES2232822T3 (es) 2005-06-01
JP3623798B2 (ja) 2005-02-23
JPH10507064A (ja) 1998-07-14
EP0760864B1 (de) 2004-11-24
WO1995032302A1 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
ATE310098T1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
ATE283368T1 (de) Für die glutamatabhängigen chloridkanäle kodierende dna
DE69434808D1 (de) Adenoviren mit veränderten faserproteinen
DE69535641D1 (de) Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
DE3786321D1 (de) Expression von protein-c.
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE69635899D1 (de) Polypeptid, das die differenzierung unterdrueckt
ATE131871T1 (de) Rezeptoren für tumornekrosisfaktor-alpha und - beta
ATE170192T1 (de) Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden
ATE93272T1 (de) Expression von protein c.
DK0973794T3 (da) Netrinreceptorer
WO1997007135A3 (en) Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof
CA2032167A1 (en) Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
FI971276A (fi) Lerk-6:ksi nimetty sytokiini
DE69433902D1 (de) Neuartige tyrosinkinase
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
DE60132571D1 (de) Für den menschlichen vanilloid-rezeptor vr3 kodierende dns
DE60129688D1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
CA2139430A1 (fr) Polypeptides ayant une activite de recepteur serotoninergique (5ht5a), acides nucleiques codant pour ces polypeptides et utilisations
ES2012283A6 (es) Procedimiento de obtencion de una proteina de endotoxina de efecto insecticida.
DK0946591T3 (da) Klonede glucagon-lignende peptid-2 receptorer
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
MXPA02011938A (es) Adn que codifica para un receptor de histamina de mamifero del subtipo h4.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties